Addex Therapeutics analyst ratings
Addex Therapeutics analyst ratings
While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Addex Therapeutics (ADXN) is trading at is $1.10, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/23/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 05/31/2022 | 1263.64% | HC Wainwright & Co. | $21 → $15 | Maintains | Buy |
| 02/11/2022 | 1809.09% | HC Wainwright & Co. | $28 → $21 | Maintains | Buy |
| 04/21/2021 | 2445.45% | HC Wainwright & Co. | → $28 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 06/23/2022 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 05/31/2022 | 1263.64% | HC Wainwright & Co. | 21 美元 → 15 美元 | 維持 | 購買 |
| 02/11/2022 | 1809.09% | HC Wainwright & Co. | 28 美元 → 21 美元 | 維持 | 購買 |
| 2021 年 4 月 21 日 | 2445.45% | HC Wainwright & Co. | → 28 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Addex Therapeutics Questions & Answers
Addex Therapeutics 問題與解答
The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on June 23, 2022. The analyst firm set a price target for $0.00 expecting ADXN to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2022年6月23日公佈了Addex Therapeutics（納斯達克股票代碼：ADXN）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計ADXN將在12個月內跌至12個月內（可能下跌-100.00％）。去年有3家分析公司公佈了評級。
The latest analyst rating for Addex Therapeutics (NASDAQ: ADXN) was provided by HC Wainwright & Co., and Addex Therapeutics downgraded their neutral rating.
HC Wainwright & Co. 提供了Addex Therapeutics（納斯達克股票代碼：ADXN）的最新分析師評級，Addex Therapeutics下調了中性評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addex Therapeutics was filed on June 23, 2022 so you should expect the next rating to be made available sometime around June 23, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Addex Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Addex Therapeutics的最新評級是在2022年6月23日公佈的，因此您應該預計下一個評級將在2023年6月23日左右公佈。
While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Addex Therapeutics (ADXN) is trading at is $1.10, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Addex Therapeutics（ADXN）評級已下調，目標股價爲0.00美元至0.00美元。Addex Therapeutics（ADXN）目前的交易價格爲1.10美元，超出了分析師的預期區間。
